Part D Protected Class Management Tools To Save Medicare $1.85bn
Executive Summary
CMS proposed rule would not eliminate any protected classes but would allow plans to impose additional restrictions on drugs in those classes. Proposal also codifies step therapy for Part B drugs.
You may also be interested in...
A Complete Retreat: “Protected Classes” Stay Protected In US Medicare
CMS has abandoned its plan to give private plans more leverage in the “protected” drug classes in Part D. It will probably be a long time before anyone tries to change the protected classes again.
Under Pressure, CMS Backs Off New Part D Protected Class Management
Decision in final rule marks a setback in the Trump Administration’s game plan for lowering drug prices. But CMS proceeds with codifying previous guidance allowing step therapy for Part B drugs in Medicare Advantage.
CMS Part D Protected Class Restrictions Drawing Bipartisan Concerns In Congress
Congressional objections to proposal join opposition by patient and physician groups.